English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/24877
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 0 veces en Web of Knowledge®  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer

AutorMoura Lima, Eleonidas; Rodríguez Burbano, Rommel; Rey, Juan A.
Palabras claveDNA methylation
Gastric cancer
ANAPC1
CDKN2A
TP53
Fecha de publicaciónjun-2008
EditorAssociação Brasileira de Divulgação Científica
CitaciónBrazilian Journal of Medical and Biological Research 41(6): 539-543 (2008)
ResumenGastric cancer is the forth most frequent malignancy and the second most common cause of cancer death worldwide. DNA methylation is the most studied epigenetic alteration, occurring through a methyl radical addition to the cytosine base adjacent to guanine. Many tumor genes are inactivated by DNA methylation in gastric cancer. We evaluated the DNA methylation status of ANAPC1, CDKN2A and TP53 by methylation-specific PCR in 20 diffuse- and 26 intestinal-type gastric cancer samples and 20 normal gastric mucosa in individuals from Northern Brazil. All gastric cancer samples were advanced stage adenocarcinomas. Gastric samples were surgically obtained at the João de Barros Barreto University Hospital, State of Pará, and were stored at -80 degrees C before DNA extraction. Patients had never been submitted to chemotherapy or radiotherapy, nor did they have any other diagnosed cancer. None of the gastric cancer samples presented methylated DNA sequences for ANAPC1 and TP53. CDKN2A methylation was not detected in any normal gastric mucosa; however, the CDKN2A promoter was methylated in 30.4% of gastric cancer samples, with 35% methylation in diffuse-type and 26.9% in intestinal-type cancers. CDKN2A methylation was associated with the carcinogenesis process for ~30% diffuse-type and intestinal-type compared to non-neoplastic samples. Thus, ANAPC1 and TP53 methylation was probably not implicated in gastric carcinogenesis in our samples. CDKN2A can be implicated in the carcinogenesis process of only a subset of gastric neoplasias.
Descripción5 pages, 2 figures, 1 table.-- et al.
Versión del editorhttp://dx.doi.org/10.1590/S0100-879X2008000600017
URIhttp://hdl.handle.net/10261/24877
DOI10.1590/S0100-879X2008000600017
ISSN0100-879X
Aparece en las colecciones: (IIBM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Status of ANAPC1.pdf498,01 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.